What’s Behind the Vaccine Feud Between Pfizer and the Feds?

1 min read

Relationships are important — especially when there’s a massive effort to distribute COVID-19 vaccines under way. There have been reports recently, though, hinting that Pfizer‘s (NYSE: PFE) relationship with the U.S. government could be strained. In this Motley Fool Live video recorded on Dec. 18, 2020, healthcare and cannabis editor/analyst Olivia Zitkus and Fool.com writer Keith Speights discuss what’s behind the feud between Pfizer and the feds.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Looking for Top International Stocks? You Might Not Have to Look Very Far

Next Story

3 Moves to Make Before Getting a New Credit Card in 2021

Latest from Blog